Abstract:OBJECTIVE:To evaluate the inhibitory effect of small interfering RNA (siRNA) on the expressions of hypoxia inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) in retinal neovascularization in the mouse.METHODS:HIF-1alpha siRNA recombinant plasmid was constructed. Liposome mediated the expressive plasmid of enhanced green fluorescent protein (EGFP) pEGFP-N1 complex was injected into the vitreous of C57BL/6J mice. The expression of GFP was observed in retinal flat-mounts one day after injection. Randomized controlled trial was performed. There were totally ninety (seven-day-old) C57BL/6J mice in which seventeen mice were chosen as normal group and seventy-three mice were divided into five groups randomly including control model group, vector group and gene therapy group (HIF-1alpha siRNA group, VEGF siRNA group and co-transfection group), in which retinal neovascularization was induced by hypoxia. Liposome with vector plasmid, HIF-1alpha siRNA and VEGF165 siRNA were injected into the vitreous in the vector group, HIF-1alpha siRNA group and VEGF siRNA group respectively one day before mice were moved out to room air from the cabin. Liposome with HIF-1alpha siRNA and VEGF165 siRNA was injected in the co-transfection group at the same time point. Fluorescent angiography was used to assess the vascular pattern. The proliferative neovascular response was quantified by counting the nuclei of new vessels extending from the retina into the vitreous in cross-sections. HIF-1alpha and VEGF levels in retinas were measured by reverse transcriptase-polymerase chain reaction and Western blot. Significant differences between groups were evaluated by one-way analysis of variance, followed by a least-significant difference analysis.RESULTS:The GFP expression in retinal cells was observed one day after injection of liposome mediated pEGFP-N1 complex. Neovascular tufts and fluorescein leakage were decreased in gene therapy group especially in co-transfection group compared to the control model group. The neovascular nuclei were decreased in gene therapy group [HIF-1alpha siRNA group (27.73 +/- 2.33), VEGF siRNA group (15.43 +/- 3.23), co-transfection group (8.70 +/- 2.88)] compared to the other three groups (F = 3016.537, P < 0.01). The expression of HIF-1alpha mRNA and protein in retinas were increased in control model group (1.08 +/- 0.06, 0.383 +/- 0.009) and vector group (1.09 +/- 0.05, 0.386 +/- 0.010) as compared with normal group (0.81 +/- 0.07, 0.035 +/- 0.003), while decreased 57.4% and 52.5% respectively in the HIF-1alpha siRNA group (0.46 +/- 0.06, 0.182 +/- 0.008) as compared with control model group (F = 139.804, 2686.001; P < 0.01). The expression of VEGF mRNA and protein in retinas were increased significantly in control model group (1.53 +/- 0.07, 0.340 +/- 0.004) and vector group (1.59 +/- 0.06, 0.337 +/- 0.009) as compared with normal group (0.27 +/- 0.08, 0.051 +/- 0.008), while decreased significantly in gene therapy group especially co-transfection group (decreased 85.6% and 80.9% respectively) as compared with control model group (F = 421.423, 2513.583; P < 0.01).CONCLUSIONS:HIF-1alpha siRNA and VEGF165 siRNA can inhibit retinal neovascularization in the mouse effectively. Co-transfection of these two siRNAs shows the greatest inhibitory effect.

Construction and functional identification of siRNA adenoviral vector targeting HIF-1α in mouse

Construction of the Recombinant Adenovirus RNA Interference Vector of Human Hypoxia-Inducible Transcription Factor-1Α Gene and Its Effect on Expression of HIF-1α Gene in Human Lung Adenocarcinoma Cells SPCA-1

Construction of a Lentiviral Vector Carrying Shrna Against HIF-1α and Generation of a GL261 Cell Line Stably Transfected with This Vector

[Construction of Shrna Expression Vector Pwh1 and Its Function in Silencing the HIF1 Gene].

Construction and Identification of HIF-1αRNAi Lentiviral Vector

Construction and Identification of Mir RNAi Lentiviral Vector Targeting for HIF-1α

Regulation of HIF-1α Expression by Small Interfering RNA Targeting HIF-1αin Human Vascular Endothelial Cells

Construction and identification of HIF-1α targeted RNAi lentiviral vector

Construction of miRNA RNAi Expression Vector Targeting Human HIF-1α and its Suppression Effect on Lovo Cells

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

Construction of shRNA Lentiviral Vector Targeting Mice IL-35 Gene and Identification of RNAi Efficiency

The Construction of Sirna Plasmid Targeting Mouse HIF-1α and in Vitro Study of Its Inhibition Effect

Inhibitory effect of interfering RNA targeting HIF-1α protein in mice retina

Inhibition of Hypoxia-Inducible Factor-1α and Endothelial Progenitor Cell Differentiation by Adenoviral Transfer of Small Interfering RNA in Vitro

Construction of HIF-1 Alpha Gene Specific Short Hairpin RNA Expressing Plasmid and Effect on Human Colon Carcinoma Cell

[Inhibitory Effect of Interfering RNA Targeting HIF-1alpha and VEGF on Retinal Neovascularization in the Mouse].

Construction of a vector carrying a small hairpin RNA targeting the HIF-1α gene and its expression in gastric cancer cells

Construction of RNAi Adenoviral Shuttle Vector Targeting Both HIF-1α and Survivin Synchronously

Inhibition of a Small Interfering Dsrna Targeting Hypoxia Inducible Factor-1Α on Retinal Neovascularization in Mice

Construction of the Adenovirus Expressing Mice EGFR SiRNA and its Effect on the Mice EL-4 Cell Line

[The Inhibition of VEGF Expression Induced by HIF-1alpha RNA Interference].